Spring Genetics operates an advanced family based breeding program for Nile tilapia, with breeding nucleus operations in Miami, Florida, USA. The Spring Genetics stock has been selected for key traits such as fast growth, survivability and yield, and more recently for increased resistance to Streptococcus iniae and S. agalactiae Ib, Francisella and TilV. Selection of disease resistance is based on controlled challenge testing of nucleus families. Additional key traits such as resistance to other pathogens, improved feed conversion efficiency, tolerance to salinity and high/low temperatures are currently assessed for implementation. Benchmark Genetics Tilapia is distributing genetically improved, high performing materials to integrated companies and affiliated multiplication hatcheries throughout the Americas and Asia .
Company Details
- Employees
- 8
- Founded
- 2009
- Address
- 21200 Sw 177th Ave, Miami,florida 33187,united States
- Industry
- Fisheries
- NAICS
-
FishingFinfish FishingShellfish FishingOther Marine Fishing
- Website
- https://www.spring-genetics.com
- HQ
- MIAMI, Florida
Spring Genetics Questions
Spring Genetics's website is https://www.spring-genetics.com
Spring Genetics's LinkedIn profile is https://www.linkedin.com/company/spring-genetics
Spring Genetics has
8 employees.
View email and phone details for 8
employees at Spring Genetics.
Spring Genetics's industry is
Fisheries
Spring Genetics's top competitors are
Aquagen,
Biomar,
Inve Aquaculture,
Xelect Ltd,
Aquabiotech Group,
Genomar Genetics Brasil,
The Center For Aquaculture Technologies (Cat),
Laboratorio Aquagen,
Benchmark Holdings Plc,
Genomar Genetics.
Spring Genetics's categories are Fisheries
Spring Genetics's founding year is 2009
